Semaglutide: all 426 studies that test it
Page 1 of 5. Open to participants first (151), then studies with results posted, then the rest; newest registration first within each.
- Lean Mass Changes With Semaglutide in Adults With Type 1 Diabetes and Overweight/Obesity.RecruitingNCT07891156Phase 2/3
- Semaglutide for the Treatment of Cannabis Use DisorderNot yet recruitingNCT07879612Phase 2
- Short Term Effects of Semaglutide on Body Composition and PerformanceNot yet recruitingNCT07874971Not applicable
- Long-Term Effects of Semaglutide on Body Composition and Performance in RunningNot yet recruitingNCT07874932Not applicable
- FutureShape FamilyNot yet recruitingNCT07872904Phase 4
- Immediate Versus Criterion-triggered Semaglutide for Suboptimal Clinical Response One Year After Primary Metabolic and Bariatric SurgeryNot yet recruitingNCT07859189Phase 4
- Tapered Versus Abrupt Discontinuation of Semaglutide After Treatment of Recurrent Weight Gain or Suboptimal Response Following Metabolic and Bariatric SurgeryNot yet recruitingNCT07859176Phase 4
- Semaglutide Given Before and After Conversion of Sleeve Gastrectomy to Roux-en-Y Gastric Bypass for Recurrent Weight GainNot yet recruitingNCT07859163Phase 4
- Semaglutide 2.4 mg Once Weekly for Recurrent Weight Gain After Metabolic and Bariatric Surgery (RESURGE)Not yet recruitingNCT07859150Phase 4
- Semaglutide Before Primary Metabolic and Bariatric Surgery in Patients With BMI 60 kg/m² or HigherNot yet recruitingNCT07859137Phase 4
- Patient-centred Intervention With Virtual Support for Obesity and Kidney Transplant AccessNot yet recruitingNCT07858331Phase 4
- A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Semaglutide MedicationRecruitingNCT07855133Phase 1
- SEMAFORCRANIO : Multicenter, Double-blind, Parallel, Randomized Controlled Trial of the Efficacy of Semaglutide in Hypothalamic Obesity Secondary to Craniopharyngioma in Children Aged 12 to 17 YearsNot yet recruitingNCT07845994Phase 3
- A Research Study Looking Into How a High Dose of s.c. Semaglutide Works With Emptying of the Stomach in People With Excess Body WeightNot yet recruitingNCT07845578Phase 1
- Evaluate the Safety and Tolerability of Multiple Doses of JMT206 Injection in Obese ParticipantsNot yet recruitingNCT07840729Phase 1
- Semaglutide, Weight Loss, and LNG-IUD for Conservative Treatment of Endometrial Atypical Hyperplasia and Grade 1 Endometrial CancerNot yet recruitingNCT07820358Phase 2
- Postpartum Semaglutide to Reduce Cardiometabolic Risk After Gestational Diabetes MellitusNot yet recruitingNCT07797036Phase 2/3
- OBESIAL: A Prospective Interventional Real-world Study of a Multidisciplinary Obesity Management ProgrammeRecruitingNCT07779343Not applicable
- Semaglutide Dose Effects on Metabolic and Stress Hormone, Craving and Alcohol Use OutcomesNot yet recruitingNCT07772960Phase 1
- Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body WeightRecruitingNCT07770841Phase 3
- Semaglutide and Structured Lifestyle Support to Improve Heart and Blood Vessel Health in Postmenopausal Obese Breast Cancer Survivors Taking Aromatase InhibitorsNot yet recruitingNCT07769047Phase 4
- Effects of Semaglutide on Brain Dopamine Responses to Food Cues in Adults With Obesity and Food Addiction TendenciesRecruitingNCT07732426Not applicable
- Semaglutide for Low Back PainNot yet recruitingNCT07731256Phase 2
- A Proof-of-Concept Study to Evaluate Topical-Lingual Semaglutide in Adults With ObesityRecruitingNCT07728383Phase 4
- Preoperative Semaglutide Prior to Radical ProstatectomyNot yet recruitingNCT07727473Early Phase 1
- Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's DiseaseRecruitingNCT07651319Phase 1/2
- Glucagon-Like Peptide-1 Receptor Agonists to Attenuate Metabolic Risk in Individuals With Duchenne Muscular DystrophyNot yet recruitingNCT07642635Phase 1/2
- GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular CancerRecruitingNCT07627191Early Phase 1
- Brown Adipose Tissue as a Mechanistic Determinant of Semaglutide Treatment Response in Obesity (BAT-Sema Study)Not yet recruitingNCT07621640Not applicable
- GLP-1 Agonists for Prevention of Recurrent Hypertriglyceridemic Acute PancreatitisNot yet recruitingNCT07617155Phase 4
- GLP-1 Receptor Agonist in Primary Intracerebral Hemorrhage: A Phase 2 Randomized TrialNot yet recruitingNCT07613437Phase 2
- Translational Health Research Into Vascular and Neurocognitive Effects of Weight LossNot yet recruitingNCT07592546Phase 4
- Personalized Pharmaco-Lifestyle Interventions for Severe Mental Illnesses (LIFETRAIN)Not yet recruitingNCT07586150Not applicable
- Effect of Semaglutide on Healing of Foot Ulcers in Type 2 Diabetes PatientsRecruitingNCT07581145Phase 3
- Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)Enrolling by invitationNCT07547878Phase 4
- Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscle Health)RecruitingNCT07527195Phase 1
- Effect of Semaglutide on Cannabis Use in Adults With Cannabis Use DisorderRecruitingNCT07523633Phase 2
- Glucagon-like Peptide-1 Receptor Agonists for Endovascular Stroke ThrombectomyNot yet recruitingNCT07511543Phase 2
- Exercise and Diabetes Interventions to Improve Brain Health in Older Adults With Type 2 DiabetesNot yet recruitingNCT07485062Phase 4
- DECODE - Haemodynamic Effects Of Semaglutide and Tirzepatide - a Series of Pilot StudiesNot yet recruitingNCT07483801Phase 4
- A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese AdultsRecruitingNCT07465965Phase 1
- GLP-1 RA for Stage 1 Type 1 DiabetesNot yet recruitingNCT07430332Phase 2
- Safety, Tolerability and Pharmacokinetics of a Subcutaneous Semaglutide ImplantNot yet recruitingNCT07430059Phase 1
- Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With DiabetesRecruitingNCT07428746Phase 3
- Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in PsoriasisRecruitingNCT07401992Phase 4
- Pathogenesis of Chronic Kidney Disease Associated With Metabolic Dysfunction- Associated Fatty Liver Disease (MAFLD) and Treatment Response of Oral Semaglutide.Not yet recruitingNCT07391267Not applicable
- Semaglutide PrIor to CathEeter Ablation in Patients With Atrial FibrillationNot yet recruitingNCT07389941Phase 4
- Triple Hypoglycemic Regimens In Patients With Newly Diagnosed Type 2 Diabetes MellitusRecruitingNCT07374328Phase 1/2
- IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol SecretionRecruitingNCT07361874Not applicable
- Effect of Semaglutide and Tirzepatide Combined With Exercise in ObesityNot yet recruitingNCT07319975Not applicable
- Side-to-Side Duodeno-ileostomy Versus Semaglutide in Adults With Obesity and Type 2 DiabetesRecruitingNCT07317115Not applicable
- GLP1-RAs Effects on Inflammatory and Endothelial Biomarkers in T2DMRecruitingNCT07314684Phase 4
- Semaglutide and Tirzepatide for Genetic Aging Delay in Adults With ObesityRecruitingNCT07293325Not applicable
- Semaglutide (Wegovy) Treatment for TrichotillomaniaNot yet recruitingNCT07282769Phase 2
- Waiting on Atrial Fibrillation Intervention Therapy (WAIT) StudyRecruitingNCT07275697Phase 4
- The Impact of Semaglutide Compared to Energy Restriction on Type 2 DiabetesRecruitingNCT07272343Phase 4
- Anti-atherosclerotic Efficacy of Selected Antidiabetic Drugs in Patients With Coronary Artery Disease and Pre-diabetesRecruitingNCT07254572Phase 4
- A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body WeightRecruitingNCT07253285Phase 3
- GLP-1 Receptor Agonists in Non-diabetic Patients With Psoriatic ArthritisNot yet recruitingNCT07251556Phase 4
- Effect of Semaglutide on Embryo Quality in Overweight and Obese Patients Undergoing In Vitro Fertilization.RecruitingNCT07242534Phase 4
- A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney DiseaseRecruitingNCT07239570Phase 4
- Repurposing Semaglutide for the Treatment of Cocaine Use DisorderRecruitingNCT07227948Phase 2
- Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)RecruitingNCT07225816Phase 1
- GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIVRecruitingNCT07221214Phase 2
- Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)RecruitingNCT07218354Phase 3
- Individualized Pharmacological Approach to Obesity in Patients With Bipolar DisorderRecruitingNCT07213466Phase 4
- Glutide for Ending MethamphetamineRecruitingNCT07204249Phase 2
- Oral Semaglutide in Patients With Alzheimer's DiseaseNot yet recruitingNCT07200622Phase 2
- Can Fat-Burning Shots Boost Fertility? Comparing Weight-Loss Injections vs. Healthy Habits for Obese Men With Low Sperm HealthNot yet recruitingNCT07179120Phase 2
- Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or ObesityRecruitingNCT07136714Phase 4
- Improved Treatment and Monitoring of Alzheimer's DiseaseNot yet recruitingNCT07135245Phase 2
- A Study of the Effect of (S)-Pindolol Benzoate (ACM-001.1) on Lean Body Mass (LBM) in Obese Patents During (PROACT 1), and Post-semaglutide Therapy (PROACT 2)RecruitingNCT07101939Phase 2
- Semaglutide in Patients Undergoing Transcatether Aortic Valve ReplacementNot yet recruitingNCT07090343Phase 3
- The Role of Glucagon-Like Peptide-1 Receptor Agonists in Coronary Artery Diseases and Their Potential MechanismsNot yet recruitingNCT07073053Phase 4
- Semaglutide for Smoking Cessation in Patients With DiabetesRecruitingNCT07059377Phase 3
- Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 SemaglutideRecruitingNCT07040592Phase 2
- Efficacy of Semaglutide in Improving Neurological Outcomes After Endovascular Thrombectomy for Acute Ischemic Stroke: A Randomized Double-Blind Controlled TrialNot yet recruitingNCT07030621Phase 3
- Brain Plasticity and GLP-1 Receptor Agonist Treatment for ObesityNot yet recruitingNCT07021937Phase 3
- The Role of the Amylin Analogue Cagrilintide in Bone MetabolismRecruitingNCT07010432Phase 1
- Protein Supplementation Intervention on Body WeightRecruitingNCT06989203Not applicable
- Impact of Semaglutide on Tobacco Use and Related Health BehaviorsRecruitingNCT06986993Phase 4
- GLP-1 Plus Lifestyle for Overall Wellness: Find Your Way ForwardNot yet recruitingNCT06977438Phase 4
- Assessing Incretin Therapy for Cardiovascular Risk Reduction and Diabetes Remission( ITCRDR Study)Enrolling by invitationNCT06959784Phase 4
- Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility StudyEnrolling by invitationNCT06954090Phase 4
- Effect of Semaglutide in Patients With Psoriasis and ObesityRecruitingNCT06937060Phase 3
- Early Reinitiation of Semaglutide Post-Sleeve Gastrectomy in YouthRecruitingNCT06934655Phase 3
- Semaglutide for the Prevention Of Post-Transplant Diabetes MellitusNot yet recruitingNCT06913023Phase 2/3
- Semaglutide Treatment in Type 1 DiabetesNot yet recruitingNCT06909006Phase 3
- A Clinical Trial to Evaluate The Effects of Semaglutide and Empagliflozin Combined to Automated Insulin Delivery on Diabetes Control in Adults Living With Type 1 DiabetesRecruitingNCT06894784Phase 3
- PEG-rhGH and Semaglutide Combination Therapy in Non-Diabetic Obese AdultsNot yet recruitingNCT06863363Phase 4
- JOULE - Metabolic Adaptation to Weight Loss in Response to a Behavioural Lifestyle Program With or Without Semaglutide in Adolescents With ObesityRecruitingNCT06852391Phase 4
- Semaglutide's Weight Loss Effects in ObesityNot yet recruitingNCT06825793Not applicable
- A Study Investigating Oral Semaglutide in People with Open-Angle GlaucomaRecruitingNCT06792422Phase 4
- Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke After Endovascular TreatmentNot yet recruitingNCT06788626Phase 3
- Characterization and Management of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)Not yet recruitingNCT06764056Not applicable
- Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 DiabetesRecruitingNCT06706284Phase 4
- Semaglutide for Helping Opioid RecoveryRecruitingNCT06639464Phase 2
- A Phase III Study Comparing the Weight Loss Effects of Semaglutide Injection and Wegovy®Not yet recruitingNCT06633783Phase 3
- Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 DiabetesRecruitingNCT06613854Phase 4
- Semaglutide's Effect on Renal Hemodynamics and Function in Patients With Type 2 Diabetes Mellitus and NephropathyNot yet recruitingNCT06555146Not applicable